Growth Metrics

Orthopediatrics (KIDS) Receivables - Net (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Receivables - Net for 10 consecutive years, with $53.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 27.11% to $53.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.8 million, a 27.11% increase, with the full-year FY2025 number at $53.8 million, up 27.11% from a year prior.
  • Receivables - Net was $53.8 million for Q4 2025 at Orthopediatrics, up from $51.3 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $53.8 million in Q4 2025 to a low of $16.6 million in Q1 2021.
  • A 5-year average of $33.3 million and a median of $34.2 million in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: increased 4.24% in 2021, then skyrocketed 49.84% in 2023.
  • Orthopediatrics' Receivables - Net stood at $17.9 million in 2021, then soared by 38.22% to $24.8 million in 2022, then skyrocketed by 39.58% to $34.6 million in 2023, then increased by 22.36% to $42.4 million in 2024, then grew by 27.11% to $53.8 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Receivables - Net are $53.8 million (Q4 2025), $51.3 million (Q3 2025), and $53.8 million (Q2 2025).